当前位置:
X-MOL 学术
›
Journal of Consulting and Clinical Psychology
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
A controlled trial of adaptive disclosure-enhanced to improve functioning and treat posttraumatic stress disorder.
Journal of Consulting and Clinical Psychology ( IF 4.5 ) Pub Date : 2024-03-01 , DOI: 10.1037/ccp0000873 Brett T Litz 1 , Julie Yeterian 2 , Danielle Berke 3 , Ariel J Lang 4 , Matt J Gray 5 , Tasha Nienow 6 , Sheila Frankfurt 7 , Jeanette Irene Harris 8 , Shira Maguen 9 , Luke Rusowicz-Orazem 10
Journal of Consulting and Clinical Psychology ( IF 4.5 ) Pub Date : 2024-03-01 , DOI: 10.1037/ccp0000873 Brett T Litz 1 , Julie Yeterian 2 , Danielle Berke 3 , Ariel J Lang 4 , Matt J Gray 5 , Tasha Nienow 6 , Sheila Frankfurt 7 , Jeanette Irene Harris 8 , Shira Maguen 9 , Luke Rusowicz-Orazem 10
Affiliation
OBJECTIVE
This is a randomized controlled trial (NCT03056157) of an enhanced adaptive disclosure (AD) psychotherapy compared to present-centered therapy (PCT; each 12 sessions) in 174 veterans with posttraumatic stress disorder (PTSD) related to traumatic loss (TL) and moral injury (MI). AD employs different strategies for different trauma types. AD-Enhanced (AD-E) uses letter writing (e.g., to the deceased), loving-kindness meditation, and bolstered homework to facilitate improved functioning to repair TL and MI-related trauma.
METHOD
The primary outcomes were the Sheehan Disability Scale (SDS), evaluated at baseline, throughout treatment, and at 3- and 6-month follow-ups (Brief Inventory of Psychosocial Functioning was also administered), the Clinician-Administered PTSD Scale (CAPS-5), the Dimensions of Anger Reactions, the Revised Conflict Tactics Scale, and the Quick Drinking Screen.
RESULTS
There were statistically significant between-group differences on two outcomes: The intent-to-treat (ITT) mixed-model analysis of SDS scores indicated greater improvement from baseline to posttreatment in the AD-E group (d = 2.97) compared to the PCT group, d = 1.86; -2.36, 95% CI [-3.92, -0.77], t(1,510) = -2.92, p < .001, d = 0.15. Twenty-one percent more AD-E cases made clinically significant changes on the SDS than PCT cases. From baseline to posttreatment, AD-E was also more efficacious on the CAPS-5 (d = 0.39). These differential effects did not persist at follow-up intervals.
CONCLUSION
This was the first psychotherapy of veterans with TL/MI-related PTSD to show superiority relative to PCT with respect to functioning and PTSD, although the differential effect sizes were small to medium and not maintained at follow-up. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
中文翻译:
一项增强适应性披露的对照试验,以改善功能和治疗创伤后应激障碍。
目的 这是一项随机对照试验 (NCT03056157),对 174 名患有与创伤性丧失 (TL) 和精神伤害(MI)。 AD 针对不同的创伤类型采用不同的策略。 AD-增强型(AD-E)使用写信(例如,给死者)、慈爱冥想和强化家庭作业来促进功能的改善,以修复与 TL 和 MI 相关的创伤。方法 主要结果是 Sheehan 残疾量表 (SDS),在基线、整个治疗过程以及 3 个月和 6 个月的随访时进行评估(还进行了心理社会功能简要量表)、临床医生管理的 PTSD 量表 (CAPS) -5)、愤怒反应的维度、修订后的冲突策略量表和快速饮酒屏幕。结果 两个结果存在统计学上显着的组间差异: SDS 评分的意向治疗 (ITT) 混合模型分析表明,与对照组相比,AD-E 组 (d = 2.97) 从基线到治疗后有更大的改善。 PCT组,d=1.86; -2.36,95% CI [-3.92,-0.77],t(1,510) = -2.92,p < .001,d = 0.15。与 PCT 病例相比,在 SDS 上发生临床显着变化的 AD-E 病例多出 21%。从基线到治疗后,AD-E 对 CAPS-5 也更有效 (d = 0.39)。这些差异效应在随访期间不会持续存在。结论 这是第一个针对患有 TL/MI 相关 PTSD 的退伍军人的心理治疗,在功能和 PTSD 方面显示出相对于 PCT 的优越性,尽管差异效应大小为小到中等,且在随访中未维持。 (PsycInfo 数据库记录 (c) 2024 APA,保留所有权利)。
更新日期:2024-03-01
中文翻译:
一项增强适应性披露的对照试验,以改善功能和治疗创伤后应激障碍。
目的 这是一项随机对照试验 (NCT03056157),对 174 名患有与创伤性丧失 (TL) 和精神伤害(MI)。 AD 针对不同的创伤类型采用不同的策略。 AD-增强型(AD-E)使用写信(例如,给死者)、慈爱冥想和强化家庭作业来促进功能的改善,以修复与 TL 和 MI 相关的创伤。方法 主要结果是 Sheehan 残疾量表 (SDS),在基线、整个治疗过程以及 3 个月和 6 个月的随访时进行评估(还进行了心理社会功能简要量表)、临床医生管理的 PTSD 量表 (CAPS) -5)、愤怒反应的维度、修订后的冲突策略量表和快速饮酒屏幕。结果 两个结果存在统计学上显着的组间差异: SDS 评分的意向治疗 (ITT) 混合模型分析表明,与对照组相比,AD-E 组 (d = 2.97) 从基线到治疗后有更大的改善。 PCT组,d=1.86; -2.36,95% CI [-3.92,-0.77],t(1,510) = -2.92,p < .001,d = 0.15。与 PCT 病例相比,在 SDS 上发生临床显着变化的 AD-E 病例多出 21%。从基线到治疗后,AD-E 对 CAPS-5 也更有效 (d = 0.39)。这些差异效应在随访期间不会持续存在。结论 这是第一个针对患有 TL/MI 相关 PTSD 的退伍军人的心理治疗,在功能和 PTSD 方面显示出相对于 PCT 的优越性,尽管差异效应大小为小到中等,且在随访中未维持。 (PsycInfo 数据库记录 (c) 2024 APA,保留所有权利)。